Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00939471 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis

A NA study of Chronic Sinusitis, sponsored by Integra LifeSciences Corporation.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT00939471 is a NA study of Chronic Sinusitis that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 44 participants, below the 191-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00939471, a NA study of Chronic Sinusitis, has completed, sponsored by Integra LifeSciences Corporation.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

A non-randomized, multi-center, prospective, clinical study intended to evaluate the safety and efficacy of balloon sinuplasty devices in pediatric patients with longstanding sinusitis following failed medical management.

Conditions Studied

Interventions

  • DEVICE Relieva™ Balloon Sinuplasty™ System

Study Locations (1)

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2007-04-01
Est. Completion 2010-05-01
Phase NA

Sponsor

Integra LifeSciences Corporation

60 total trials

What the Registry Record Tells You About NCT00939471

The ClinicalTrials.gov registry entry for NCT00939471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 191-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (77% lower). The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which Relieva™ Balloon Sinuplasty™ System is the first listed.

NCT00939471 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT00939471 about?

NCT00939471 is a clinical study titled "Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis". A non-randomized, multi-center, prospective, clinical study intended to evaluate the safety and efficacy of balloon sinuplasty devices in pediatric patients with longstanding sinusitis following failed medical management.

What is the current status of trial NCT00939471?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2007-04-01. Estimated completion is 2010-05-01.

What conditions does trial NCT00939471 study?

This clinical trial studies the following conditions: Chronic Sinusitis.

What interventions are being tested in trial NCT00939471?

The interventions under investigation include: Relieva™ Balloon Sinuplasty™ System (DEVICE).

Who is sponsoring clinical trial NCT00939471?

This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00939471 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.